查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2017149

外科網片市場：依產品類型、固定方法、原料類型、應用和最終用戶分類－2026-2032年全球市場預測

Surgical Mesh Market by Product Type, Fixation Technique, Source Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，外科網片市場價值將達到 27.6 億美元，到 2026 年將成長至 29.9 億美元，到 2032 年將達到 47.9 億美元，複合年成長率為 8.16%。

主要市場統計數據
基準年 2025 27.6億美元
預計年份：2026年 29.9億美元
預測年份 2032 47.9億美元
複合年成長率 (%) 8.16%

詳細概述外科網片生態系統，將現代醫學中的材料創新、臨床期望和採購壓力連結起來。

外科網片仍然是重組和修復手術的關鍵基礎，其材料性能、固定可靠性和臨床療效相互交織，共同決定患者的康復軌跡。過去十年，臨床醫生和製造商一直在應對由聚合物化學創新、生物相容性整合和技術改進所塑造的不斷變化的市場環境。同時，監管和報銷壓力也調整了產品的市場推廣曲線。因此，相關人員必須綜合解讀臨床證據和價值鏈的實際情況，從而優先考慮那些既能保證安全性又能帶來價值的投資。

材料科學的突破、固定技術的創新、監管的加強以及供應的韌性正在重新定義整個外科網片行業的競爭重點。

外科網片產業正經歷一場變革性的轉變，這場變革正在重塑產品研發的重點和臨床應用模式。可吸收聚合物和混合結構的進步正在重新定義外科醫生如何在短期支撐和長期組織整合之間取得平衡，而表面工程和孔隙率的改進則旨在減少感染和粘連。因此，醫療設備的差異化越來越依賴材料的創新性，以及在功能性結果和併發症減少方面可證實的優勢。

評估美國關稅政策如何重塑外科網片整個價值鏈的採購決策、製造在地化和採購慣例。

美國關稅的實施對外科網片產業的相關人員產生了多方面的影響，包括採購、生產策略和臨床應用。關稅帶來的成本壓力促使買家和製造商重新評估其籌資策略，並加快對近岸外包和國內生產能力的關注，以降低進口關稅風險並提高庫存應對力。隨著採購團隊努力穩定總到岸成本，產品規格、包裝和物流正受到更嚴格的審查，以尋找能夠抵消額外關稅的效率提升機會。

透過多層次細分分析，明確了決定產品策略和採用的因素，例如材料、固定方法、供應商、臨床應用和最終用戶。

深入的市場區隔揭示了外科網片市場中附加價值與風險交會的領域。根據產品類型，可吸收網片和不可吸收網片的差異決定了不同的研發重點。可吸收網片（包括Polyglactin和聚乙醇酸乙醇酸網片等亞型）的創新著重於可預測的吸收特性和組織重塑，而不可吸收網片（例如膨體聚四氟乙烯網片、聚酯網片和聚丙烯網片）的改進則著重於長期機械支撐和耐久性。這些基於材料的差異會影響臨床方案、植入選擇標準和術後後續觀察策略。

全部區域在臨床實踐、法律規範和採購行為方面存在細微的區域差異，因此需要製定量身定做的商業化策略。

區域趨勢對外科網片產品的研發、行銷和分銷有顯著影響。在美洲，市場活動通常著重於臨床證據的累積、報銷方案的調整以及對微創解決方案的需求，採購流程則由綜合醫療網路和大規模醫院集團主導，他們優先考慮產品的價值和供應穩定性。同時，在歐洲、中東和非洲（EMEA）地區，監管協調和多元化的醫療資金籌措模式正在影響產品的推廣路徑，這要求製造商調整實證材料和定價策略，以滿足各國不同的需求。

競爭差異化如何根植於臨床證據、製造彈性、夥伴關係生態系統以及以外科醫生為中心的價值提案。

主要企業之間的競爭格局日益取決於它們能否將臨床證據、生產靈活性和策略夥伴關係關係整合為一個連貫的價值提案。投資長期療效研究和完善的上市後監測的市場領導往往能贏得外科界和採購委員會的更強信任。同時，靈活的中小型企業和Start-Ups正透過專注於新型材料、差異化固定系統或針對特定手術的解決方案，開闢利基市場，以應對持續存在的臨床挑戰。

為製造商和供應商提供切實可行的策略措施，以增強在不斷變化的外科網片領域的韌性、臨床應用和價值實現。

產業領導者應優先考慮一系列切實可行的策略，將市場洞察轉化為持久的競爭優勢。首先，投資建立多元化的製造地，將國內生產能力與值得信賴的區域合作夥伴結合，以應對關稅風險並縮短前置作業時間。其次，加速建立醫療設備特性與以病人為中心的治療結果之間的關聯證據，無論手術類型如何，從而加強採購談判和與支付方的溝通。第三，開發模組化產品線，使臨床醫生能夠在可吸收和不可吸收材料之間進行選擇，並選擇適合手術偏好和醫療機構能力的固定方法。

一個嚴謹的多方面研究框架，結合了對臨床醫生的訪談、採購負責人的觀點以及綜合文獻，得出了基於證據的、可操作的結論。

本報告的研究結合了對臨床醫生、採購經理和行業專家的訪談，以及對同行評審的臨床文獻、監管申報文件和製造商文件的系統性回顧。主要研究包括與多學科外科醫生進行半結構式訪談，以了解真實的臨床模式，以及與供應鏈和採購專家進行討論，以了解營運限制和決策標準。次要研究提供了材料科學進展、更新的監管指南和已發表的臨床結果研究方面的背景資訊。

對影響外科網片市場產品策略、臨床應用和營運韌性的相互關聯的因素進行明確的整合。

總之，外科網片領域正處於一個轉折點，材料創新、固定技術進步、監管趨嚴以及地緣政治壓力交織在一起，迫使企業重新定義策略重點。能夠透過高品質證據證明臨床價值、調整生產和籌資策略以降低關稅和供應風險、並提供以臨床醫生為中心的解決方案（從而簡化選擇並改善治療效果）的企業，才能最終取得成功。研發、監管、臨床和銷售團隊之間的跨職能協作對於將技術優勢轉化為永續的市場差異化至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 外科網片市場：依產品類型分類

  • 吸水網
    • Polyglactin網
    • 聚乙醇酸網
  • 不吸水網
    • 膨脹聚四氟乙烯網
    • 聚酯網布
    • 聚丙烯網

第9章：以固定方式分類的外科網片市場

  • 使用黏合劑進行固定
    • 黏合劑
    • 合成黏合劑
  • 縫合固定
    • 連續縫合
    • 間斷縫合
  • 使用褶皺進行修復
    • 吸水黏性材料
    • 不吸水黏性材料

第10章：依原料類型分類的外科網片市場

  • 生物起源
  • 合成

第11章 外科網片市場：依應用領域分類

  • 乳房重建
  • 疝氣修補術
  • 骨盆器官脫垂
  • 重組手術
  • 應力性尿失禁
  • 創傷/外科性創傷

第12章 外科網片市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第13章 外科網片市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 外科網片市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 外科網片市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國外科網片市場

第17章：中國外科網片市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Angiologica BMSrl
  • Aran Biomedical
  • ASSUT Europe SpA
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Betatech Medical
  • BG Medical LLC
  • BioCer Entwicklungs-GmbH
  • Boston Scientific Corporation
  • Coloplast Corp.
  • Cousin Biotech SAS
  • Deep Blue Medical Advances, Inc.
  • Dipromed Srl
  • Dolphin Sutures
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc
  • KLS Martin Group
  • Lotus Surgicals
  • Medtronic PLC
  • Novus Scientific AB
  • Tela Bio, Inc.
  • THT Bio-Science
  • Vitrex Medical A/S
  • WL Gore & Associates, Inc.
Product Code: MRR-0355054AC4C7

The Surgical Mesh Market was valued at USD 2.76 billion in 2025 and is projected to grow to USD 2.99 billion in 2026, with a CAGR of 8.16%, reaching USD 4.79 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.76 billion
Estimated Year [2026] USD 2.99 billion
Forecast Year [2032] USD 4.79 billion
CAGR (%) 8.16%

A nuanced overview of the surgical mesh ecosystem that connects material innovation, clinical practice expectations, and procurement pressures in contemporary care

Surgical mesh continues to be a cornerstone in reconstructive and reparative surgery, where material performance, fixation reliability, and clinical outcomes intersect to determine patient recovery trajectories. Over the past decade, clinicians and manufacturers have navigated an evolving landscape shaped by innovations in polymer chemistry, biologic integrations, and technique refinement, all while regulatory scrutiny and reimbursement pressures recalibrate the adoption curve. Consequently, stakeholders must interpret clinical evidence alongside supply chain realities to prioritize investments that deliver both safety and value.

In parallel, patient expectations for minimally invasive procedures and reduced complication rates amplify the importance of device design and fixation strategy. Health systems increasingly demand robust real-world evidence and cost-effectiveness data that demonstrate improved patient-reported outcomes and shorter lengths of stay. Therefore, a modern market perspective extends beyond device attributes to encompass lifecycle performance, training requirements for surgical teams, and alignment with evolving clinical pathways.

This introduction frames the subsequent analysis by emphasizing the interplay between materials science, clinical practice, and macroeconomic forces, setting the stage for a detailed examination of transformative shifts, tariff impacts, segmentation nuances, and regional dynamics that will guide strategic decisions for manufacturers, providers, and investors.

How material science breakthroughs, fixation innovations, regulatory tightening, and supply resilience are redefining competitive priorities across the surgical mesh sector

The surgical mesh landscape is undergoing transformative shifts that are reshaping product development priorities and clinical adoption patterns. Advances in absorbable polymers and hybrid constructs are redefining how surgeons balance short-term support with long-term tissue integration, while improvements in surface engineering and porosity are targeting reductions in infection and adhesion. As a result, device differentiation increasingly hinges on demonstrable benefits in functional outcomes and complication mitigation rather than on material novelty alone.

Concurrently, fixation approaches are evolving from traditional sutures and tacks toward adhesive-based and minimally invasive techniques that prioritize operative efficiency and reduced patient discomfort. This shift is reinforced by a growing emphasis on standardized training and procedure-specific guidance, which together support more consistent outcomes across care settings. In addition, regulatory landscapes have tightened, prompting manufacturers to invest in more rigorous clinical evidence generation and post-market surveillance that, in turn, inform purchasing decisions and payer discussions.

Supply chain resilience and regional manufacturing footprints are also rising in strategic importance amid geopolitical uncertainties and trade policy shifts. Collectively, these dynamics are accelerating consolidation and collaborative partnerships between device innovators, contract manufacturers, and clinical research organizations to ensure agility and compliance while sustaining innovation pipelines.

Assessment of how U.S. tariff policy has reshaped sourcing decisions, manufacturing localization, and procurement practices across the surgical mesh value chain

The application of tariffs in the United States has created multifaceted implications across procurement, manufacturing strategy, and clinical adoption for surgical mesh stakeholders. Tariff-driven cost pressures have prompted purchasers and manufacturers to re-evaluate sourcing strategies, accelerating interest in nearshoring and domestic production capabilities to reduce exposure to import levies and to improve inventory responsiveness. As procurement teams seek to stabilize total landed costs, product specifications and packaging logistics have garnered closer scrutiny to identify efficiency opportunities that offset incremental duties.

Manufacturers facing higher import costs have adopted a range of responses, including localizing certain manufacturing steps, renegotiating supplier contracts, and optimizing component sourcing to preserve competitive pricing. These adjustments have practical downstream effects: supply continuity becomes a procurement priority, contractual terms incorporate more robust contingency provisions, and product portfolios are assessed for margin resilience under altered cost structures. Hospital purchasing groups and ambulatory centers are increasingly integrating tariff sensitivity into vendor evaluations, emphasizing suppliers that demonstrate transparent cost modeling and supply chain redundancy.

Clinicians and hospital administrators must also consider the indirect clinical impact of tariff-induced shifts, since changes in availability, lead times, or product selection can influence procedure planning and inventory management. Consequently, organizations are aligning cross-functional teams-supply chain, clinical leadership, and finance-to navigate the operational implications while maintaining care quality and patient safety.

A layered segmentation analysis clarifying material, fixation, source, clinical application, and end user drivers that determine product strategy and adoption

Insightful segmentation reveals where incremental value and risk converge within the surgical mesh market. Based on product type, the distinction between absorbable mesh and non-absorbable mesh underpins divergent development priorities: absorbable mesh innovations, which include polyglactin mesh and polyglycolic mesh subtypes, emphasize predictable resorption profiles and tissue remodeling, whereas non-absorbable mesh variants such as expanded polytetrafluoroethylene mesh, polyester mesh, and polypropylene mesh focus on long-term mechanical support and durability. These material-based differences cascade into clinical protocols, implant selection criteria, and postoperative surveillance strategies.

Fixation technique segmentation further clarifies adoption dynamics, with adhesive-based fixation, suture-based fixation, and tack-based fixation each presenting distinct trade-offs. Adhesive-based approaches split into biological adhesives and synthetic adhesives, offering varying biocompatibility and handling characteristics, while suture-based fixation differentiates continuous sutures and interrupted sutures in terms of procedural time and tissue tension control. Tack-based fixation, categorized by absorbable tacks and non-absorbable tacks, raises considerations around long-term foreign body presence and potential late complications, which affect surgeon preference and patient counseling.

Source type segmentation, distinguishing biological and synthetic origins, intersects with regulatory pathways and reimbursement discussions, and influences clinician perceptions of infection risk and integration. Application-based segmentation identifies areas of clinical focus-breast reconstruction, hernia repair, pelvic organ prolapse, reconstructive surgery, stress urinary incontinence, and traumatic or surgical wounds-each with unique performance and evidence requirements. End user segmentation across ambulatory surgical centers, clinics, and hospitals shapes purchasing behaviors, contract size, and inventory management, thereby informing go-to-market tactics and training investments.

Regional nuances in clinical practice, regulatory frameworks, and procurement behavior that require tailored commercialization strategies across the Americas, EMEA, and Asia-Pacific

Regional dynamics significantly influence how surgical mesh products are developed, marketed, and distributed. In the Americas, market activity often centers on clinical evidence generation, reimbursement alignment, and demand for minimally invasive solutions, with procurement processes driven by integrated delivery networks and large hospital groups that prioritize value and supply stability. Conversely, in Europe, Middle East & Africa, regulatory harmonization efforts and diverse healthcare funding models shape adoption pathways, prompting manufacturers to tailor evidence dossiers and pricing strategies to meet heterogeneous national requirements.

Asia-Pacific markets are characterized by rapid infrastructure investment, growing surgeon proficiency in advanced techniques, and an appetite for cost-competitive innovations. These markets also present opportunities for local manufacturing partnerships and technology transfer agreements that can accelerate market entry while addressing regional price sensitivity. Each region's distinct combination of clinical practice patterns, regulatory expectations, and procurement mechanisms necessitates regionally calibrated commercialization plans that balance global product platforms with locally relevant evidence and distribution strategies.

Across regions, collaboration between manufacturers and local clinical leaders supports more effective training, adoption, and post-market data collection, enabling companies to adapt product messaging and support services in alignment with regional priorities and care delivery models.

How competitive differentiation is anchored in clinical evidence, manufacturing agility, partnership ecosystems, and surgeon-focused value propositions

Competitive dynamics among key companies are increasingly defined by their ability to integrate clinical evidence, manufacturing agility, and strategic partnerships into coherent value propositions. Market leaders that invest in longitudinal outcomes research and robust post-market surveillance tend to command stronger trust among surgical communities and procurement committees. At the same time, agile smaller players and startups are carving niches by focusing on novel materials, differentiated fixation systems, or procedure-specific solutions that address persistent clinical challenges.

Strategic collaboration is prevalent, with alliances spanning co-development agreements, contract manufacturing partnerships, and clinical research collaborations that accelerate time-to-evidence. Many organizations are also exploring adjacent capabilities such as surgical instrumentation, training platforms, and digital solutions for tracking outcomes to strengthen adoption and customer retention. Operational excellence in quality systems and regulatory compliance bolsters market access, while transparent supply chain practices and localized sourcing strategies mitigate exposure to trade disruptions.

For competitors, sustained differentiation will depend on aligning product performance with clear economic and clinical value propositions, supported by accessible education for clinicians and robust customer service models that reduce barriers to adoption across diverse care settings.

Practical strategic moves for manufacturers and providers to strengthen resilience, clinical adoption, and value realization in a shifting surgical mesh environment

Industry leaders should prioritize a set of actionable strategies to translate market insights into durable competitive advantage. First, invest in diversified manufacturing footprints that combine domestic capabilities with trusted regional partners to manage tariff exposure and to shorten lead times. Second, accelerate evidence generation that links device characteristics to patient-centered outcomes across procedure types, thereby strengthening procurement conversations and payer engagement. Third, develop modular product lines that allow clinicians to select between absorbable and non-absorbable options and to choose fixation methods that align with procedural preferences and site capabilities.

Leaders must also commit to enhanced clinician education programs that embed best practices for fixation and mesh selection, supported by simulation and proctoring that reduce variability in outcomes. From a commercial perspective, pricing and contracting strategies should reflect total cost of care rather than unit price alone, and account for regional reimbursement landscapes. Finally, pursue digital and service-based offerings-such as outcomes tracking platforms and training curricula-that create stickiness with customers and provide ongoing real-world data to inform iterative product improvements.

Collectively, these measures will enable organizations to respond to regulatory intensification, supply chain volatility, and evolving clinical expectations while maintaining a focus on sustainable growth and patient safety.

A rigorous, multi-source research framework combining clinician interviews, procurement perspectives, and literature synthesis to ensure evidence-driven and actionable conclusions

The research underpinning this report combined primary engagement with clinicians, procurement leaders, and industry experts alongside systematic review of peer-reviewed clinical literature, regulatory filings, and manufacturer documentation. Primary research included semi-structured interviews with surgeons across multiple specialties to capture real-world practice patterns, as well as discussions with supply chain and procurement professionals to understand operational constraints and decision criteria. Secondary research provided contextual grounding in material science developments, regulatory guidance updates, and published clinical outcome studies.

Data synthesis relied on triangulation across multiple sources to validate thematic findings, with particular attention to consistency between clinical preferences, purchasing behavior, and manufacturer strategies. Segmentation mapping was applied to align product attributes, fixation techniques, source types, clinical applications, and end user dynamics into an integrated framework that supports actionable recommendations. Quality assurance steps included cross-validation by subject matter experts and iterative review cycles to ensure clarity and practical relevance.

The methodology recognizes inherent limitations: evolving regulatory positions and emerging clinical evidence may alter specific interpretations over time, and regional heterogeneity means that local market intelligence should supplement this analysis when making operational decisions.

Conclusive synthesis of the interconnected forces shaping product strategy, clinical adoption, and operational resilience within the surgical mesh market

In conclusion, the surgical mesh sector is at an inflection point where material innovation, fixation technique evolution, regulatory rigor, and geopolitical pressures converge to redefine strategic priorities. Success will favor organizations that can demonstrate clinical value through high-quality evidence, adapt manufacturing and sourcing strategies to mitigate tariff and supply risks, and deliver clinician-centric solutions that simplify choice and improve outcomes. Cross-functional alignment between R&D, regulatory, clinical affairs, and commercial teams will be essential to translate technical advantages into sustainable market differentiation.

Looking ahead, stakeholders should prepare for continued emphasis on patient-reported outcomes, real-world evidence, and cost-effective care pathways that support adoption across care settings. By focusing on resilient operations, targeted clinical investments, and partnerships that bridge technical and commercial capabilities, organizations can position themselves to meet the dual imperatives of safety and value while capturing opportunities in an increasingly sophisticated and demanding market environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Mesh Market, by Product Type

  • 8.1. Absorbable Mesh
    • 8.1.1. Polyglactin Mesh
    • 8.1.2. Polyglycolic Mesh
  • 8.2. Non-Absorbable Mesh
    • 8.2.1. Expanded Polytetrafluoroethylene Mesh
    • 8.2.2. Polyester Mesh
    • 8.2.3. Polypropylene Mesh

9. Surgical Mesh Market, by Fixation Technique

  • 9.1. Adhesive-Based Fixation
    • 9.1.1. Biological Adhesives
    • 9.1.2. Synthetic Adhesives
  • 9.2. Suture-Based Fixation
    • 9.2.1. Continuous Sutures
    • 9.2.2. Interrupted Sutures
  • 9.3. Tack-Based Fixation
    • 9.3.1. Absorbable Tacks
    • 9.3.2. Non-Absorbable Tacks

10. Surgical Mesh Market, by Source Type

  • 10.1. Biological
  • 10.2. Synthetic

11. Surgical Mesh Market, by Application

  • 11.1. Breast Reconstruction
  • 11.2. Hernia Repair
  • 11.3. Pelvic Organ Prolapse
  • 11.4. Reconstructive Surgery
  • 11.5. Stress Urinary Incontinence
  • 11.6. Traumatic/Surgical Wounds

12. Surgical Mesh Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Surgical Mesh Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Surgical Mesh Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Surgical Mesh Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Surgical Mesh Market

17. China Surgical Mesh Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Angiologica B.M. S.r.l.
  • 18.7. Aran Biomedical
  • 18.8. ASSUT Europe S.p.A.
  • 18.9. B. Braun Melsungen AG
  • 18.10. Becton, Dickinson and Company
  • 18.11. Betatech Medical
  • 18.12. BG Medical LLC
  • 18.13. BioCer Entwicklungs-GmbH
  • 18.14. Boston Scientific Corporation
  • 18.15. Coloplast Corp.
  • 18.16. Cousin Biotech SAS
  • 18.17. Deep Blue Medical Advances, Inc.
  • 18.18. Dipromed Srl
  • 18.19. Dolphin Sutures
  • 18.20. Integra LifeSciences Corporation
  • 18.21. Johnson & Johnson Services, Inc
  • 18.22. KLS Martin Group
  • 18.23. Lotus Surgicals
  • 18.24. Medtronic PLC
  • 18.25. Novus Scientific AB
  • 18.26. Tela Bio, Inc.
  • 18.27. THT Bio-Science
  • 18.28. Vitrex Medical A/S
  • 18.29. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL MESH MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SURGICAL MESH MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SURGICAL MESH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL MESH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SURGICAL MESH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL MESH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SURGICAL MESH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLACTIN MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYGLYCOLIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL MESH MARKET SIZE, BY EXPANDED POLYTETRAFLUOROETHYLENE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYESTER MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL MESH MARKET SIZE, BY POLYPROPYLENE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL MESH MARKET SIZE, BY CONTINUOUS SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL MESH MARKET SIZE, BY INTERRUPTED SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL MESH MARKET SIZE, BY ABSORBABLE TACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE TACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL MESH MARKET SIZE, BY BIOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL MESH MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL MESH MARKET SIZE, BY BREAST RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL MESH MARKET SIZE, BY HERNIA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL MESH MARKET SIZE, BY PELVIC ORGAN PROLAPSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL MESH MARKET SIZE, BY RECONSTRUCTIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL MESH MARKET SIZE, BY STRESS URINARY INCONTINENCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL MESH MARKET SIZE, BY TRAUMATIC/SURGICAL WOUNDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL MESH MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL MESH MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL MESH MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL MESH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS SURGICAL MESH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL MESH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GCC SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 197. GCC SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 198. GCC SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 201. GCC SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 202. GCC SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. G7 SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 230. G7 SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 231. G7 SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 233. G7 SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 234. G7 SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 235. G7 SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. G7 SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. NATO SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 241. NATO SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 242. NATO SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 244. NATO SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 245. NATO SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 246. NATO SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. NATO SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL MESH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA SURGICAL MESH MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA SURGICAL MESH MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA SURGICAL MESH MARKET SIZE, BY ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA SURGICAL MESH MARKET SIZE, BY NON-ABSORBABLE MESH, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA SURGICAL MESH MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA SURGICAL MESH MARKET SIZE, BY ADHESIVE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA SURGICAL MESH MARKET SIZE, BY SUTURE-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA SURGICAL MESH MARKET SIZE, BY TACK-BASED FIXATION, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA SURGICAL MESH MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA SURGICAL MESH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA SURGICAL MESH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)